Status:
COMPLETED
Compassion and Metacognition in Schizotypal Personality
Lead Sponsor:
Tages Onlus
Conditions:
Schizotypal Personality Disorder
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The purpose of this study is to assess the safety and efficacy of a newly developed psychotherapy for schizotypal personality disorder. This new form of psychotherapy integrates compassion focused the...
Detailed Description
After being informed about the study and potential risks, all patients giving written informed consent will undergo a psychological assessment so as to determine eligibility for study entry. Patients ...
Eligibility Criteria
Inclusion
- \- Being diagnosed with Schizotypal Personality Disorder at SCID-5-AMPD
Exclusion
- Being under psychotherapy or psychopahrnacological treatment
- Being diagnosed with schizophrenia and other psychotic disorders
- Being diagnosed with bipolar disorder
- Being diagnosed with intelletual disability
- Being diagnosed with any neurological disases
Key Trial Info
Start Date :
December 15 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 20 2021
Estimated Enrollment :
16 Patients enrolled
Trial Details
Trial ID
NCT04764708
Start Date
December 15 2020
End Date
December 20 2021
Last Update
June 21 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Centro di Psicologia e Psicoterapia Tages Onlus - Firenze
Florence, FI, Italy, 50137